Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
17.67 USD | +2.26% | -9.33% | -15.00% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 307M |
---|---|---|---|---|---|
Net income 2024 * | -37M | Net income 2025 * | -64M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-10.3
x | P/E ratio 2025 * |
-6.3
x | Employees | 38 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 38.71% |
Latest transcript on Cartesian Therapeutics, Inc.
1 day | -6.59% | ||
1 week | -4.21% | ||
Current month | -11.38% | ||
1 month | -8.85% | ||
3 months | -23.42% | ||
Current year | -16.45% |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.02% | 0 M€ | 0.00% | - | |
0.01% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 17.56 | +1.62% | 35 585 |
24-04-18 | 17.28 | -6.59% | 35,798 |
24-04-17 | 18.5 | -1.44% | 46,691 |
24-04-16 | 18.77 | -1.16% | 69,454 |
24-04-15 | 18.99 | -2.06% | 200,685 |
Delayed Quote Nasdaq, April 18, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.45% | 307M | |
-3.30% | 102B | |
+1.79% | 96.07B | |
-1.43% | 21.66B | |
-18.35% | 20.77B | |
-8.72% | 18.53B | |
-40.31% | 16.91B | |
-26.84% | 13.79B | |
+0.59% | 13.33B | |
+20.86% | 10.94B |
- Stock Market
- Equities
- RNAC Stock